BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, February 15, 2026
Home
»
Topics
» Regulatory
Regulatory
RSS
Lumavita is granted marketing authorization in Switzerland for pentamycin for vaginitis
Sep. 1, 2009
FDA approves Embeda for moderate to severe chronic pain
Aug. 17, 2009
Saphris approved by FDA for schizophrenia and bipolar I disorder
Aug. 17, 2009
Invega approved for the treatment of schizoaffective disorder
Aug. 6, 2009
Invega Sustenna approved for acute and maintenance schizophrenia treatment
Aug. 5, 2009
FDA approves AstraZeneca and Bristol-Myers' Onglyza for type 2 diabetes
Aug. 4, 2009
Wyeth's Prevenar 13 pneumococcal vaccine approved in Chile
July 16, 2009
FDA granted marketing approval for AMAG's Feraheme in chronic kidney disease
July 1, 2009
FDA approves Allergan's Ozurdex for macular edema following retinal vein occlusion
June 22, 2009
FDA approves Novartis' monoclonal antibody Ilaris for children and adults with CAPS
June 18, 2009
Previous
1
2
…
1066
1067
1068
1069
1070
1071
1072
1073
1074
…
1342
1343
Next
RSS